Adobe Stock 377641579

Annual Report 2020

Highlights

  • 31 new investments approved for a total amount of EUR 168 M and 21 investments signed for a total amount of EUR 194 M
  • 14 Technical Assistance subsidies approved to enhance the impact of investment projects
  • A portfolio of 144 outstanding investments, directly responsible for 240 thousand jobs and contributing indirectly to an additional 3.1 million jobs
  • 10 loans fully reimbursed and 1 equity investment exited
  • An Emergency Financing Facility of EUR 50 M created
  • Total investment capital reached EUR 1,062 M (+4%)
  • EUR 56 M capital injected by the Belgian state, of which EUR 25 M earmarked to combat climate change
  • BIO suffers a loss of EUR 14.6 M
  • First close of the SDG Frontier Fund at EUR 25.3 M and the first 4 investments signed
BIO Annual Report2019 Cover hero

Annual Report 2019

Highlights

  • BIO made 31 new commitments, totaling EUR 199 million. This brought the total net signed commitments up to EUR 783 million.
  • BIO signed up to the 2X Challenge, which calls for DFIs to join together to collectively mobilise USD 3 billion in gender-smart investments.
  • BIO made its first investments out of a new facility targeting projects with a particularly high development impact but with high risks and relatively lower expected financial return: Fairtrade Access Fund and Alterfin.
  • BIO launched the SDG Frontier Fund, enabling private individual and institutional investors to co-invest with BIO into private equity SME Funds.
  • BIO reached over EUR 1 billion in investment capital
  • BIO refreshed its baseline: “Investing in a sustainable future”, expressing our aspiration for sustainable livelihoods all around the globe.
201907-Annual Report2018_Hero

Annual Report 2018

Highlights

  • BIO decided on 22 new investments for a total of €150M.
  • BIO monitored 83 outstanding loan investments. BIO employees also personally participated in boards and committees of its 52 equity investments.
  • BIO’s Special Operations team intensively accompanied clients in trouble. They managed to reduce BIO’s total provisions for the company’s outstanding investments from 5,96 % (2017) to 5,02 % (2018).
  • BIO granted 10 subsidies totalling € 850,000 to new capacity building and technical assistance projects.
  • 15 loans were reimbursed and 6 equity investments were exited.
  • BIO established a new facility for investing in small projects with a particularly high development impact but with high risks and relatively lower expected financial return.
  • In 2018, investment capital grew thanks to a capital injection by the Belgian State of € 61 M, of which € 20 M was earmarked for investments to combat climate change. Furthermore, the substantial net gain of € 67.8 M of 2017 on an investment in a Cambodian MFI was converted into capital, bringing BIO’s means available for investment to € 937.7 M.
  • BIO has a brand new logo. The colours signal we are Belgian. Its style refers to our affiliation with Belgium’s development cooperation.
DSCN0191

Annual Report 2017

Highlights

  • 27 new investments decided for a total of 161 million euro, including
    • A participation in a micro-financing institution in the Maghreb providing capital to over ten thousand mainly women and youth to establish and develop microbusinesses
    • A participation in a fund investing in projects in Africa that combine sustainable forestry management with providing jobs and income to tens of thousands of people living in and around the forests.
    • A participation in a fund that enables its investees to provide micro-insurance to low-income people in South-East Asia.
    • Four investments to provide 494 thousand people with renewable energy and thereby avoid 181,600 tonnes CO2 eq Greenhouse Gas Emissions per year.
  • Monitoring of 145 million euro of outstanding loan investments, personal involvement in our 340 million euro of equity investments to make them successful
  • 7 subsidies totalling 1 million euro to new capacity building and technical assistance projects of our clients, and one investment support grant
  • 18 loans fully reimbursed and 6 equity investments exited, virtually all companies involved sufficiently strengthened to continue to develop their businesses without further BIO support
  • Development of BIO’s agriculture strategy increasing its relevance for small-holders
  • Growth of BIO’s investment capital by 117 million euro: 50-million-euro capital injection by the Belgian state and 67-million-euro net capital gain through the sale of our participation in a Cambodian MFI
  • Fundraising for a facility for institutional private investors to co-invest in BIO’s projects